Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Confo Therapeutics

Confo Therapeutics?uq=BoBgMMEs
2015 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Grant LATEST DEAL TYPE
$1.24M LATEST DEAL AMOUNT
11 INVESTORS
Description

Developer of a drug discovery technology designed to address unmet medical needs. The company's drug discovery technology utilizes pipeline of GPCR targeted therapeutics and antibody fragments, known as Confobodies, to lock inherently unstable functional conformation, enabling physicians to be empowered with novel agonists for better therapeutic intervention.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • Pleinlaan 2
  • Building E, 7th Floor, Room E7.6
  • 1050 Brussels
  • Belgium
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Confo Therapeutics’s full profile, request a free trial.

Confo Therapeutics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Grant 20-Feb-2018 $1.24M 00.000 Completed Generating Revenue
2. Grant 01-Feb-2017 00.000 00.000 Completed Startup
1. Seed Round 01-Feb-2016 $7.44M $7.44M Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Confo Therapeutics Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Vlaanderen verbeelding werkt Limited Partner 000 0000 000000 0
The Brussels Institute for Research and Innovation Government 000 0000 000000 0
Vlaams Agentschap Innoveren en Ondernemen Endowment University 000 0000 000000 0
Capricorn Venture Partners Venture Capital Minority 000 0000 000000 0
Michigan Investment in New Technology Startups Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 11 investors. Get the full list »

Confo Therapeutics Executive Team (5)

Name Title Board
Seat
Contact
Info
Cedric Ververken Ph.D Chief Executive Officer & Board Member
Christel Menet Ph.D Chief Scientific Officer
Toon Laeremans Ph.D Co-Founder & Head of Technology
Jan Steyaert Ph.D Co-Founder & Chairman of Scientific Advisory Board

1 Former Executive

You’re viewing 4 of 5 executives. Get the full list »

Confo Therapeutics Board Members (8)

Name Representing Role Since Contact
Info
Cedric Ververken Ph.D Confo Therapeutics Chief Executive Officer & Board Member 000 0000
Chris De Jonghe Ph.D PMV Board Member 000 0000
Christina Takke Ph.D V-Bio Ventures Board Member 000 0000
Ekaterina Smirnyagina Ph.D Capricorn Venture Partners Board Member 000 0000
Els Beirnaert VIB Board Member 000 0000

1 Former Board Member

You’re viewing 5 of 8 board members. Get the full list »